REBECCA LANDRY: Open Payments
NPI 1669724464 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,417 in 73 payments from 17 companies in 2025. Trend: 2023 $1,122 · 2024 $1,315 · 2025 $1,417
Food & beverage: $1,417
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $262 |
| Janssen Biotech, Inc. | 8 | $256 |
| ABBVIE INC. | 12 | $212 |
| Ardelyx, Inc. | 9 | $154 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| PFIZER INC. | 4 | $60 |
| Phathom Pharmaceuticals, Inc. | 6 | $52 |
| Celltrion USA Inc. | 2 | $50 |
| Ipsen Biopharmaceuticals, Inc | 3 | $49 |
| QOL Medical, LLC | 3 | $48 |
Products named: REZDIFFRA, TREMFYA, IBSRELA, RINVOQ, LINZESS, DUPIXENT, XIFAXAN, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
